Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Merck & Co.
Biotech
Merck strides onto Pfizer’s turf with pivotal vaccine data
The candidate matched Prevnar 20 for shared serotypes and performed better for 10 of its 11 unique serotypes, positioning Merck to file for approvals.
Nick Paul Taylor
Nov 28, 2023 8:20am
UPDATE: FDA AdComm votes against Merck's cough med
Nov 17, 2023 4:53pm
FDA skeptical of Merck's gefapixant, even after cough recount
Nov 16, 2023 11:00am
VectorY raises $138M to push forward ALS program
Nov 13, 2023 10:26am
Daiichi Sankyo ups revenue forecast thanks to huge Merck deal
Oct 31, 2023 10:10am
AbbVie CEO says company favored internal work over Daiichi deal
Oct 27, 2023 11:41am
